Language selection

Search

Patent 1087906 Summary

Third-party information liability

Some of the information on this Web page has been provided by external sources. The Government of Canada is not responsible for the accuracy, reliability or currency of the information supplied by external sources. Users wishing to rely upon this information should consult directly with the source of the information. Content provided by external sources is not subject to official languages, privacy and accessibility requirements.

Claims and Abstract availability

Any discrepancies in the text and image of the Claims and Abstract are due to differing posting times. Text of the Claims and Abstract are posted:

  • At the time the application is open to public inspection;
  • At the time of issue of the patent (grant).
(12) Patent: (11) CA 1087906
(21) Application Number: 283946
(54) English Title: METHOD OF PREPARING BOVINE COLOSTRUM FOR USE IN TREATING LIVESTOCK
(54) French Title: METHODE DE PREPARATION DU COLOSTRUM DE BOVIN POUR LE TRAITEMENT DES BESTIAUX
Status: Expired
Bibliographic Data
Abstracts

English Abstract



ABSTRACT OF THE DISCLOSURE
The method of preparing bovine colostrum for use in
treating livestock comprising the steps of:
(1) Collecting bovine colostrum milk:
(2) Removing substantially all of the fat from the
colostrum milk:
(3) Removing the casein from the colostrum milk to
obtain bovine colocteral whey:
(4) Dialysing the whey:
(5) Adjusting the pH of the dialysate of 4.0 to 4.5:
(6) Precipitating the whey:
(7) Removing the supernatant from the precipitated whey:
(8) Clarifying the supernatant:
(9) Adding a water, saline and phenol mixture to the
clarified supernatant to obtain the desired
concentration:
(10) Sterilizing the mixture; and
(11) Placing the sterilized mixture into containers
for subsequent storage and use.




Claims

Note: Claims are shown in the official language in which they were submitted.


The embodiments of the invention in which an exclusive
property or privilege is claimed are defined as follows:
1. The method of preparing bovine colostrum for use in
treating livestock comprising the following steps, collecting
bovine colostrum milk, removing substantially all of the fat from
the colostrum milk, removing the casein from the colostrum milk
to obtain bovine colosteral whey, dializing the why, adjusting the
pH of the dialsate to 4.0-4.5, precipitating the whey, removing the
supernant from the precipitated whey, clarifying the supernant,
adding a water, saline and phenol mixture to the clarified super-
nant to obtain the desired concentration, sterilizing the mixture,
and placing the sterilized mixture into containers for subsequent
storage and use.
2. The method of claim 1 wherein said bovine colostrum
milk is frozen after collection, said frozen milk then being par-
tially thawed, said fat being removed by skimming off the fat from
the partially thawed milk.
3. The method of claim 2 wherein substantially all of
the remaining fat is removed after the partially frozen milk is
completely thawed.
4. The method of claim 3 wherein said fat is removed by
centrifugal separation.
5. The method of claim 1 wherein the casein is removed
by:
(a) adding approximately 1.0-2.0 mg of CaCl2 per liter
of milk;
(b) adding approximately 0.5-1.5 tablets of rennin per
liter of milk;
(c) mixing the mixture;
(d) heating the mixture to 20-80° C;
(e) mixing the heated mixture;
(f) allowing the heated mixture to stand until the

-6-

casein precipitates from the mixture; and
(g) filtrating the casein from the mixture.
6. The method of claim 5 wherein the whey is dialized
against tap water having a temperature of 40-54° F for approxi-
mately 96-120 hours.
7. The method of claim 6 wherein the whey is precipitated
by heating the dialsate to 35-65° F.
8. The method of claim 7 wherein the supernant of the
precipitated whey is removed from the mixture and centrifuged.
9. The method of claim 8 wherein water, saline and 0.3
Phenol mixture is added to make a final bovine concentration of
100 mg %.

-7-





Description

Note: Descriptions are shown in the official language in which they were submitted.


^~ Milk co~tains one or more proteins o~ ~he globulin
group although the amount present is usually quite sm~ll. The
globulin group is generally considered to be comprised of
lactoglobulin or beta lactoglobulin. The globulin of milk is
very important. Under certain conditions it enables a mother
to transmit immunity toward certain infections to her suckling.
' This takes place during the first 2 or 3 days of the young ani-
~ malls life.
- During the first few days of lactation, the secretion
of the mammary gland differs a great deal from that of normal
milk. The secretion is called colostrum. The first colostrum
is very rich in glcbulin and fills the special needs of the
newborn animal. Among these is a need for globulin, for the
blood of the newborn of many species contains much less that the
normal amount of this protein. Colostrum is an important source
of antibodies for the newborn. The antibodies may either be the
globulins themselves or are associated with the globulins.
Colostrum is generally believed to be important in the case of
.. ..
the cow, goat, sheep, pig and mare.
As previously stated, colostrum milk has been shown to
be an important factor in the resistance of infectuous diseases
,~ in the young newborn which was nature's purpose for providing
,; colostrum milk. The antibodies found in colostrum milk help the
,; newborn fight diseases as well as protect them from future
infection through immunal responses. It has also been found that
a cow can be stimulated to produce certain antibodies to bacteria
by injecting the cow before calving with antigens to the anti-
bodies desired. Further, it has been found that a cow which has
been subjected to many diseases during its lifetime will also
;' 30 have produced certain antibodies. When the cow calves, the first
milk produced by the cow will contain antibodies to the stimulants
:
: as well as the normal environmental antibodies present in the

.` ':
i' ! -2-

'~
9(~6
mammalory.
The colostrum milk is collected and the antibodies are
removed therefrom and are manufactured into an injectible solution
~.,j
;~1 which may also be used orally to benefit other animals which may
be subjected to the diseases which the particular antibodies are
peculiar to. -
Assuming that the cow has either been injected with cer-
tain antigens or that the cow simply has the normally occurring
antibodies in the colostrum milk, the colostrum milk is collected
1~ 10 after calving. Preferably, the colostrum milk is collected and
:~ frozen until a suitable quantity has been collected to enable the
process to be carried out. The freezing of the colostrum milk
also aids in subsequent removal of the fat from the colostrum
milk. Examples I and II are two examples wherein the antibodies
were recovered from the colostrum milk. Example I is the preferred
~ process of recovering the antibodies while Example II is an alter-
';.i : .
,;¦ nate method for recovering the antibodies.
.,
,i EXAMPLE I (PREFERRED )
The colostrum milk is collected and frozen. The milk is

defatted by partially thawing the frozen milk and skimming the

top liquid therefrom. Irhe remaining milk is then completely
~ ,,
'. ~ thawed and centrifugally separated to remove as much of the remain-
ing fat as possible,
The defatted colostrum milk is then precipitated by add-
,' ing 1.5 mg of CaC12 per liter of milk and by adding one tablet
;` (1.5 gram) of commercially available rennin per liter of milk.
The mi~ture is then thoroughly stirred. The solution is then
heated to 20-80C and again stirred. The solution is permitted to
,.,~

. stand for 2-5 hours and the casein in the solution is then removed

by filtration. The resultant solution is termed "bovine colosteral
~7



.,
- - ~ ., , . . , -

7~6

/
whey".
The whey is then dialyzed against tap water at 47F with
saline added for approximately 96 tG 120 hours. The pH o~ the
dialysate is adjusted to 4.0 to 4.5 with acetic acid. The whey
is then precipitated by placin~ the same in vats having a controlled
temperature of 35-65F. The supernatant is siphoned off and cen-
trifu~ed. The supernatant is then clarified by filtration. The
titre of the solution is determined in conventional fashion and a
water, saline and 0.3~ Phenol mixture is added to make a final
bovine IGG concentration of lOOmg~.
The solution is then passed through a water sterilizer
(ultraviolet) and placed in sterile 250 mg bottles and capped in
ultraviolet light. The product is then ready for use.
:, .
EXA~PLE II
The colostrum milk is collected and centrifugally se~arated
to remove as much of the fat as possible.
The defatted colostrum milk is then precipitated by adding
~"~ 1.0 - 2.0 mg. of CaC12 per liter of milk and by adding 0.5 - 1.5
tablets of commercially available rennin per liter of milk. The
. ,.
mixture is then thoroughly stirred. The solution is then heated

`~ to 20-80C and again stirred. The solution is permitted to stand
.,.,:
for 2 5 hours and the casein in the solution is then removed by
,.,.:
; filtration. The resultant solution is termed "bovine colosteral
:, : .
~` whey".

The whey is then dialyzed against tap water at 40-54F


with saline added for approximately 96 to 120 hours. The pH of

~: the dialysate is adjusted to 4.0 to 4.5 with acetic acid. The
; ~ ,
whey is then precipitated by placing the same in vats having a

controlled temperature of 35-65F. The supernatant is siphoned
,;" -.
'~ 30 off and centrifuged. The supernatant is then clarified by filtra-i, ..................................................................... . .
;~..

J ~ 4


.. . .
, . : . .. .. ... . . . . . . .

''i'' '''-"-`' ` ~ ~E~7gV6
tion. The titre oE the solution is determined in conven-tional
fashion and a water, saline and 0.3% Phenol mixture is added to ,-
; make a final bovine IGG concentration of lOOmg%.
` The solution is then passed through a water sterilizer
(ultraviolet) and placed in sterile 250 mg bottles and capped in
ultraviolet light. The product is then ready for use.
:.
The finished product may then be injected into cattle to
,~, , .
. . - .
' provide the cattle with the necessary antibodies for disease pro- '
,- tection and immunity. The liquid product may also be formed into
;, lO tablets by conventional methods for oral adminlstration if desired.
Thus it can be seen that the method of this invention i-
accomplishes at least all of its stated objectives.
.. .
.. , F
. ~ ., , ,-- .
.~ .' ( ~ .

','~': i' '
. ', ~ . ~ . .
.';.' ~ ,.
, :.; : ;


S,

,;. ` ,~


~' '.

"i~ ` i . '


~, ~
,, ! ~



':C~

... ~ ,. .. . . .

Representative Drawing

Sorry, the representative drawing for patent document number 1087906 was not found.

Administrative Status

For a clearer understanding of the status of the application/patent presented on this page, the site Disclaimer , as well as the definitions for Patent , Administrative Status , Maintenance Fee  and Payment History  should be consulted.

Administrative Status

Title Date
Forecasted Issue Date 1980-10-21
(22) Filed 1977-08-03
(45) Issued 1980-10-21
Expired 1997-10-21

Abandonment History

There is no abandonment history.

Payment History

Fee Type Anniversary Year Due Date Amount Paid Paid Date
Application Fee $0.00 1977-08-03
Owners on Record

Note: Records showing the ownership history in alphabetical order.

Current Owners on Record
PLYMATE, ROBERT R.
Past Owners on Record
None
Past Owners that do not appear in the "Owners on Record" listing will appear in other documentation within the application.
Documents

To view selected files, please enter reCAPTCHA code :



To view images, click a link in the Document Description column. To download the documents, select one or more checkboxes in the first column and then click the "Download Selected in PDF format (Zip Archive)" or the "Download Selected as Single PDF" button.

List of published and non-published patent-specific documents on the CPD .

If you have any difficulty accessing content, you can call the Client Service Centre at 1-866-997-1936 or send them an e-mail at CIPO Client Service Centre.


Document
Description 
Date
(yyyy-mm-dd) 
Number of pages   Size of Image (KB) 
Drawings 1994-04-11 1 17
Claims 1994-04-11 2 74
Abstract 1994-04-11 1 67
Cover Page 1994-04-11 1 26
Description 1994-04-11 4 194